The impact of transcranial direct current stimulation on inhibitory control in young adults

Authors

Anne L. Abbott, Baker Heart and Diabetes Institute
Mark A.A. Adelman, NYU Langone Health
Andrei V. Alexandrov, University of Alabama Hospital at Birmingham
Henry J.M. Barnett, Robarts Research Institute
Jonathan Beard, Northern General Hospital
Peter Bell, University of Leicester
Martin Bj̈orck, Uppsala Universitet
David Blacker, Sir Charles Gairdner Hospital
Clifford J. Buckley, Scott and White
Richard P. Cambria, Massachusetts General Hospital
Anthony J. Comerota, The Toledo Hospital
E. Sander Connolly, Columbia University
Alun H. Davies, Charing Cross Hospital
Hans Henning Eckstein, Klinikum rechts der Isar der Technischen Universität München
R. Faruqi, Stanford University Medical Center
Gustav Fraedrich, Medizinische Universitat Innsbruck
Peter Gloviczki, Mayo Clinic
Graeme J. Hankey, Royal Perth Hospital
Robert E. Harbaugh, Pennsylvania State University
E. Heldenberg, Shamir Medical Center
Steven J. Kittner, University of Maryland School of Medicine
Timothy J. Kleinig, The University of Adelaide
Dimitri P. Mikhailidis, UCL Medical School
Wesley S. Moore, David Geffen School of Medicine at UCLA
R. Naylor, Leicester Royal Infirmary
Andrew Nicolaides, Imperial College London
Kosmas I. Paraskevas, Klinikum Nürnberg
David M. Pelz, Western University
James W. Prichard, Yale School of Medicine

Document Type

Article

Publication Date

3-1-2012

Journal

Brain and Behavior

Volume

2

Issue

2

First Page

200

Last Page

207

URL with Digital Object Identifier

10.1002/brb3.32

Abstract

In recent years, many important discoveries have been made to challenge current policy, guidelines, and practice regarding how best to prevent stroke associated with atherosclerotic stenosis of the origin of the internal carotid artery. TheUnited States Center forMedicare andMedicaid Services (CMS), for instance, is calling for expert advice as to whether its current policies should be modified. Using a thorough review of literature, 41 leading academic stroke-prevention clinicians from the United States and other countries, have united to advise CMS not to extend current reimbursement indications for carotid angioplasty/stenting (CAS) to patients with asymptomatic carotid stenosis or to patients with symptomatic carotid stenosis considered to be at "low or standard risk from carotid endarterectomy (CEA)." It was concluded that such expansion of reimbursement indications would have disastrous health and economic consequences for the United States and any other country that may follow such inappropriate action. This was an international effort because the experts to best advise CMS are relatively few and scattered around the world. In addition, US health policy, practice, and research have tended to have strong influences on other countries. © 2012 The Authors. Published by Wiley Periodicals, Inc.